CLINICAL_TRIALS
trial_result
· 2013-01-29
Clinical Trial Update: Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the Knee [Phase 1]
Summary
A Phase 1 study evaluating MEDI-578 for knee osteoarthritis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Osteoarthritis, Pain | Phase 1 | Status: TERMINATED